Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
Journal article published in 2021 by
Ya Gao 
,
Shuzhen Shi,
Ming Liu,
Fanqi Wu,
Junhua Zhang,
Fujian Song,
JinHui Tian
,
Shuzhen Shi,
Ming Liu,
Fanqi Wu,
Junhua Zhang,
Fujian Song,
JinHui Tian
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 